Atrial fibrillation (AFib) is not heart failure. They are two distinct conditions, but they are so closely connected that each one significantly raises the risk of developing the other. AFib is an electrical problem where the upper chambers of the heart beat irregularly. Heart failure is a pumping problem where the heart can’t move blood efficiently enough to meet the body’s needs. About one-third of heart failure patients also have AFib, and when both conditions are present, the outlook is considerably worse than with either one alone.
How AFib and Heart Failure Differ
AFib is a rhythm disorder. The upper chambers of the heart fire chaotic electrical signals instead of beating in a coordinated pattern, which makes the heartbeat irregular and often too fast. Blood doesn’t get pumped out of those chambers efficiently, so it can pool there. This pooling is why AFib raises the risk of blood clots and stroke.
Heart failure means the heart muscle has become too weak or too stiff to pump blood the way it should. It’s not a sudden stop. It’s a gradual decline in the heart’s ability to keep up with demand. Some people with heart failure have a weakened squeeze (reduced ejection fraction), while others have a heart that squeezes normally but doesn’t relax and fill properly (preserved ejection fraction). Either way, blood backs up, fluid builds in the lungs or legs, and everyday activities become harder.
You can have AFib without heart failure, heart failure without AFib, or both at the same time. The confusion between them is understandable because they share symptoms and frequently coexist.
Why AFib Can Lead to Heart Failure
When AFib keeps the heart racing for weeks or months, the muscle itself starts to weaken. A persistently fast heart rate shortens the time the heart has to fill with blood between beats, reducing the amount pumped out with each contraction. Over time, the heart cells themselves break down: they burn through energy faster than they can replenish it, their internal calcium signaling goes haywire, and the muscle fibers lose their ability to contract forcefully. This process, sometimes called tachycardia-induced cardiomyopathy, can turn an otherwise healthy heart into one that meets the definition of heart failure.
The encouraging part is that this type of heart failure is often at least partially reversible. If the heart rate is brought under control or the normal rhythm is restored, the muscle can recover some or all of its pumping strength. That recovery window is one reason doctors take a persistently fast heart rate in AFib seriously, even when symptoms feel manageable.
Why Heart Failure Can Trigger AFib
The relationship runs in both directions. Heart failure causes structural changes in the heart, particularly stretching and scarring of the upper chambers. That remodeling disrupts the electrical pathways and creates the conditions for AFib to develop. The weaker the heart becomes, the more likely it is that AFib will appear. In large population studies, roughly a third of patients with heart failure that has a preserved ejection fraction also have AFib.
Overlapping Symptoms
Part of the reason people confuse these conditions is that they feel similar. Both cause shortness of breath, fatigue, dizziness, and lightheadedness. The distinguishing clue for AFib tends to be palpitations: a fluttering, pounding, or “fish flopping” sensation in the chest. Heart failure is more associated with swelling in the ankles and legs, waking up at night gasping for air, and a persistent cough from fluid in the lungs.
In practice, many people with both conditions can’t sort out which one is causing which symptom. That overlap is exactly why doctors rely on specific tests rather than symptoms alone. An EKG reveals AFib’s irregular electrical pattern. An echocardiogram measures how well the heart is pumping and whether the chambers are enlarged. Together, these tests clarify whether one or both conditions are present and how severe each is. Certain EKG changes, such as signs of thickened heart muscle or abnormal electrical patterns in specific leads, can flag that a patient with AFib is at higher risk of developing heart failure down the line.
What Happens When Both Are Present
Having AFib and heart failure together is more dangerous than having either alone. A large population study published in The Lancet Healthy Longevity found that people diagnosed with both conditions had a median survival of 3.15 years from the point both diagnoses were established. The one-year mortality rate was 31.8%, climbing to 61.4% at five years and 80.2% at ten years. These numbers were significantly worse than for people with just one of the two conditions.
Research across thousands of heart failure patients shows that AFib worsens outcomes regardless of how well the heart pumps. Whether ejection fraction is mildly reduced, preserved, or completely normal, the presence of AFib independently increases the risk of hospitalization and cardiovascular death. The worse the pumping function, the more AFib amplifies the danger.
How Treatment Addresses Both
Because these conditions feed each other, treatment often targets both simultaneously. The goals are to control the heart rate, manage fluid buildup, and reduce the risk of blood clots.
Rate-controlling medications slow the heart during AFib episodes, giving the chambers more time to fill and reducing strain on the muscle. A large nationwide study found that patients with AFib who took rate-controlling medication had a 25% lower risk of dying within one year compared to those who didn’t, and this benefit held for patients with and without heart failure. Interestingly, strict rate control (targeting a very specific heart rate) didn’t prove more effective than a more relaxed approach, so treatment tends to focus on keeping the rate reasonably controlled rather than chasing an exact number.
Blood thinners remain essential for most AFib patients to prevent stroke, but they don’t directly treat heart failure. Meanwhile, heart failure medications that reduce fluid overload and support the heart muscle can ease the burden that contributes to AFib episodes. For some patients, restoring a normal heart rhythm through catheter ablation or other procedures can improve heart function substantially, especially when AFib itself caused the heart to weaken.
The 2024 European Society of Cardiology guidelines for AFib management place comorbidity management, including heart failure, as the central pillar of care. Rather than treating AFib in isolation, the current approach emphasizes addressing everything that makes the heart vulnerable: high blood pressure, obesity, sleep apnea, diabetes, and heart failure itself. Controlling these factors reduces AFib burden and slows heart failure progression at the same time.
The Key Distinction to Remember
AFib is not heart failure, but it is one of the most important risk factors for developing it. If you have AFib, it doesn’t mean your heart is failing. It does mean the risk is elevated, particularly if your heart rate stays high for extended periods or if you have other cardiovascular risk factors. The two conditions share a biological feedback loop where each one makes the other more likely and more severe, which is why managing AFib early and aggressively can protect heart function over the long term.